Sun Pharma | Page 2 | Business Upturn

Latest Articles

Sun Pharma reports positive results from Phase 3 trials for ILUMYA

Corporates · Jul 21, 2025

blank

Nifty 50 top losers today, July 16: Shriram Finance, Eternal, Sun Pharma, Cipla, Tata Steel and more

Stock Market · Jul 16, 2025

blank

Nifty top gainers today, July 15: Hero MotoCorp, Bajaj Auto, Sun Pharma, Shriram Finance, Apollo Hospitals and more

Stock Market · Jul 15, 2025

blank

Nifty 50 top losers today, June 17: Adani Enterprises, Dr. Reddy’s, Tata Motors, Sun Pharma lead declines

Stock Market · Jun 17, 2025

blank

Sun Pharma’s Halol facility receives form 483 with 8 observations from US FDA

Corporates · Jun 14, 2025

blank

Sun Pharma shares drop over 4% as Q4 misses estimates

Stock Market · May 23, 2025

blank

Nifty 50 top losers today, April 29: Sun Pharma, UltraTech Cement, Coal India, ONGC and more

Stock Market · Apr 29, 2025

blank

Nifty 50 top gainers today, April 28: Reliance Industries, Sun Pharma, JSW Steel, Bharat Electronics and more

Stock Market · Apr 28, 2025

blank

Sun Pharma launches FEXUCLUE 40 mg in India for treatment of Erosive Esophagitis

Corporates · Apr 7, 2025

blank

Sun Pharma to acquire Checkpoint Therapeutics for Rs 3,087.30 crore

Corporates · Mar 10, 2025

blank

Sun Pharma Q3 FY25 Results: Net profit rises 24.1% YoY to Rs 3,219.6 crore, gross sales increase 10.5%

Corporates · Jan 31, 2025

By Aditya Bhagchandani

blank

Sun Pharma’s subsidiary Taro to acquire Antibe Therapeutics

Corporates · Jan 16, 2025

blank

Sun Pharma Q2 FY25 Results: Revenue grows 9% YoY to ₹13,291 crore, Net Profit jumps 27.5% YoY

Corporates · Oct 28, 2024

By Aditya Bhagchandani

blank

UBS maintains Buy call on Sun Pharma, expects 28% upside in share price

Stock Market · Oct 7, 2024

blank

Sun Pharma and Philogen enter into global licensing agreement for commercializing Fibromun

Corporates · Oct 1, 2024

Showing 30 of 52 articles